Streetbeat News

Stock Prices

INTA

Intapp shares surged following the announcement of Q3 financial results that exceeded expectations, along with FY24 guidance surpassing estimates. The company also provided Q4 adjusted EPS guidance that was above analyst predictions.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:52 pm

RNG

RingCentral has updated its FY24 revenue and adjusted EPS outlook, raising both. The total revenue forecast has been increased from $2.37B-$2.395B to $2.379B-$2.399B, slightly above the estimated $2.384B. The adjusted EPS outlook has also been raised from $3.50-$3.58 to $3.59-$3.67, surpassing the estimated $3.55.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:52 pm

CHRD

Chord Energy (NASDAQ:CHRD) reported Q1 2024 adjusted EPS of $5.10, surpassing the $4.72 estimate, but its sales of $748.3M fell short of the $776.843M forecast, marking a 2.34% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:52 pm

GMRE

Global Medical REIT (NYSE:GMRE) reported Q1 2024 FFO of $0.23 per share, surpassing the $0.21 estimate, and sales of $35.069M, exceeding the $33.938M estimate. These results represent a 9.52% beat on FFO per share and a 3.33% beat on sales estimates, despite a 3.12% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:52 pm

MTCH

Match Group shares are trading lower following the release of their Q1 financial results and the issuance of Q2 revenue guidance that fell below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:50 pm

KD

Kyndryl Holdings' shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:50 pm

RNG

RingCentral anticipates Q2 total revenue to be between $584.5M and $587.5M, slightly surpassing the estimated $585.536M. Additionally, the company expects its adjusted EPS to be between $0.87 and $0.88, exceeding the estimate of $0.85.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:49 pm

CFLT

Confluent shares surged following the announcement of its Q1 financial results, which exceeded expectations. Additionally, the company has uplifted its full-year 2024 guidance, surpassing analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:49 pm

JANX

Janux Therapeutics (NASDAQ:JANX) reported Q1 EPS of $(0.30), surpassing the $(0.33) estimate, and sales of $1.25M, exceeding the $760.00K estimate. This represents a 9.09% beat on EPS and a 64.74% beat on sales estimates, despite a 38.87% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:49 pm

BROS

Dutch Bros Inc. shares surged following the announcement of their Q1 financial results, which exceeded expectations. Additionally, the company has increased its revenue guidance for FY24, signaling stronger future performance.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:48 pm